Results 191 to 200 of about 142,249 (285)
Prognostic value of CD28⁻CD57⁺CD8⁺ T cells for early immunotherapy response in hepatocellular carcinoma: a prospective observational study. [PDF]
Zhou S +8 more
europepmc +1 more source
Impact of anti-TB drugs on modulations of T-cell-receptor-mediated signaling events in TB pleurisy patients. [PDF]
Sharma B, Joshi B, Kumar S.
europepmc +1 more source
ABSTRACT Respiratory syncytial virus (RSV) is a common virus that causes respiratory infections, posing a serious threat, particularly to infants, the elderly, and individuals with compromised immune systems. As the leading cause of lower respiratory tract infections (LRTIs) in infants, RSV is responsible for millions of cases worldwide each year.
Jie Shi +6 more
wiley +1 more source
Divergent Effects of Cytomegalovirus and Rheumatoid Arthritis on Senescent CD4<sup>+</sup> T Cells. [PDF]
Williams L +9 more
europepmc +1 more source
ABSTRACT Objective Obesity is an imperfect correlate of metabolic health. Visceral adipose tissue (VAT) characteristics are considered determinants of poor health and subcutaneous adipose tissue (SAT) considered protective. There is a gap in knowledge regarding shared vs.
Sobha Puppala +5 more
wiley +1 more source
Circulating T-lymphocyte subsets as biomarkers for immune checkpoint inhibitors in solid tumors. [PDF]
Kong Y, Chen R, Zhang J, Zhang L.
europepmc +1 more source
The combination of immune checkpoint inhibitors (ICIs) and radiotherapy synergistically enhances efficacy through an “antigen release‐immune activation” closed‐loop mechanism, significantly improving outcomes in solid tumors (e.g., lung cancer, melanoma).
Guiling Song +5 more
wiley +1 more source
Monitoring mitochondrial function in peripheral T cells to assess immune status and graft health after kidney transplantation. [PDF]
Zhang E +9 more
europepmc +1 more source
This review highlights recent advances in nanomedicine that enhance chimeric antigen receptor (CAR) T cell therapy against solid tumors. It discusses key barriers to CAR T cell efficacy and outlines nanotechnology‐based strategies to improve tumor targeting, remodel the immunosuppressive microenvironment, and integrate nanomaterials into CAR T cell ...
Stephen O’Rourke +3 more
wiley +1 more source

